Bruce Kovner serves as Executive at SYNTA PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Bruce Kovner has executed 155 insider transactions totaling $100.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 8, 2007 involved purchasing 19,317 shares valued at $160.3K.
Bruce Kovner currently holds 8,060,682 shares of SYNTA PHARMACEUTICALS CORP (SNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruce Kovner has been a net buyer of SNTA stock. They have purchased $93.3M and sold $7.4M worth of shares.
Bruce Kovner's most recent insider trade was on Jun 8, 2007, when they purchased 19,317 shares at $8.30 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 9, 2007 | SNTA | $7.2M | Purchase | 720,000 | $10.00 | Discretionary |
| Feb 9, 2007 | SNTA | $0 | Conversion | 23,648 | $N/A | Discretionary |
| Nov 17, 2006 | SNTA | $0 | Award | 2,857 | $N/A | Discretionary |